Literature DB >> 23754609

[Testosterone deficiency - an underestimated risk for men? Prevalence of hypogonadism].

T Jäger1, J Kramer, O Bätz, H Rübben, C von Ostau, T Szarvas.   

Abstract

BACKGROUND: Testosterone deficiency represents a significant health risk factor for men but the importance has so far been underestimated. Besides physiological and age-related reduction, acquired testosterone deficiency may also occur. Testosterone deficiency is a possible result of commonly occurring diseases or is itself the basis for development of different diseases. The scope of the present investigation was measurement of serum testosterone levels in different age groups.
MATERIALS AND METHODS: Serum testosterone levels were determined in samples from 5,735 healthy men at the LADR laboratory MVZ Dr. Kramer & colleagues, Geesthacht under routine conditions. The frequency of testosterone deficiency was calculated in different age groups and compared using SPSS 19.0 software.
RESULTS: Pathologically low testosterone levels (< 2.5 ng/ml) were found in 15.2 % of subjects while 37.4 % had a testosterone level lower than 3.5 ng/ml. Decreased testosterone levels were not associated with age. In addition the proportion of men with decreased serum testosterone levels was comparable in all age groups. The average serum testosterone level decreased slightly in all age groups during the period before midday.
CONCLUSIONS: The data reveal high rates of testosterone deficiency in men independent of patient age. As decreased serum testosterone levels may be the consequence of several diseases and can be causally involved in the pathogenesis of further diseases, it is strongly recommended that serum testosterone measurement should be included in the diagnostic arsenal especially when symptoms, such as loss of libido, erectile dysfunction, lack of concentration, depression, lethargy, irritability and sleep disturbance are present.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23754609     DOI: 10.1007/s00120-013-3203-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  19 in total

Review 1.  Male hormone replacement therapy including "andropause".

Authors:  J L Tenover
Journal:  Endocrinol Metab Clin North Am       Date:  1998-12       Impact factor: 4.741

2.  Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.

Authors:  A Vermeulen; J M Kaufman; V A Giagulli
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

3.  The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men.

Authors:  Thomas G Travison; Andre B Araujo; Varant Kupelian; Amy B O'Donnell; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2006-12-05       Impact factor: 5.958

Review 4.  Osteoporosis in men.

Authors:  E S Orwoll; R F Klein
Journal:  Endocr Rev       Date:  1995-02       Impact factor: 19.871

Review 5.  A practical guide to male hypogonadism in the primary care setting.

Authors:  P Dandona; M T Rosenberg
Journal:  Int J Clin Pract       Date:  2010-05       Impact factor: 2.503

6.  Lower testosterone levels predict incident stroke and transient ischemic attack in older men.

Authors:  Bu B Yeap; Zoë Hyde; Osvaldo P Almeida; Paul E Norman; S A Paul Chubb; Konrad Jamrozik; Leon Flicker; Graeme J Hankey
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

7.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe Casanueva; Gianni Forti; Aleksander Giwercman; Ilpo T Huhtaniemi; Krzysztof Kula; Margus Punab; Steven Boonen; Dirk Vanderschueren
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

8.  The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study.

Authors:  Johan Svartberg; Monica Midtby; Kaare H Bønaa; Johan Sundsfjord; Ragnar M Joakimsen; Rolf Jorde
Journal:  Eur J Endocrinol       Date:  2003-08       Impact factor: 6.664

9.  Screening for metabolic syndrome and testosterone deficiency in patients with erectile dysfunction: results from the first UK prospective study.

Authors:  Bhaskar Somani; Shahid Khan; Roland Donat
Journal:  BJU Int       Date:  2010-09       Impact factor: 5.588

Review 10.  Male hypogonadism in systemic disease.

Authors:  Rita R Kalyani; Sravanya Gavini; Adrian S Dobs
Journal:  Endocrinol Metab Clin North Am       Date:  2007-06       Impact factor: 4.741

View more
  2 in total

1.  Serum testosterone levels and symptom-based depression subtypes in men.

Authors:  Stephanie Rodgers; Martin Grosse Holtforth; Michael P Hengartner; Mario Müller; Aleksandra A Aleksandrowicz; Wulf Rössler; Vladeta Ajdacic-Gross
Journal:  Front Psychiatry       Date:  2015-05-04       Impact factor: 4.157

2.  Influence of fetal Leydig cells on the development of adult Leydig cell population in rats.

Authors:  Dong-Mei Su; Ying Feng; Lin Wang; Yi-Lun Wu; Ren-Shan Ge; Xue Ma
Journal:  J Reprod Dev       Date:  2018-03-06       Impact factor: 2.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.